2659 — Shanghai Bao Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$32.37bn
- HK$32.14bn
- CNY6.16m
Annual cashflow statement for Shanghai Bao Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -160 | -364 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | -6.27 | 153 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 4.02 | -40 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -140 | -220 |
| Capital Expenditures | -136 | -118 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 0 | -3.85 |
| Sale of Fixed Assets | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -136 | -122 |
| Financing Cash Flow Items | -4.29 | -6.97 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 123 | 543 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -151 | 202 |